Finance

Beta
Lists
ALXO:NASDAQ
ALX Oncology Holdings Inc
US$ १.९७
-७.२९%
(-०.१५) 1D
US$ १.९८
+०.५१% (+०.०१००)
After hours
Closed: जुलाई १३, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALXO...
Open
US$ २.०८
High
US$ २.१३
Low
US$ १.९४
Mkt. cap
२६.४५ करोड
Avg. vol.
१७.४८ लाख
Volume
१२.१७ लाख
52-wk high
US$ २.६६
52-wk low
US$ ०.४४
EPS
-US$ १.४९
Beta
०.४२
Shares outstanding
१३.४६ करोड
No. of employees
४३
Open
US$ २.०८
High
US$ २.१३
Low
US$ १.९४
Mkt. cap
२६.४५ करोड
Avg. vol.
१७.४८ लाख
Volume
१२.१७ लाख
52-wk high
US$ २.६६
52-wk low
US$ ०.४४
EPS
-US$ १.४९
Beta
०.४२
Shares outstanding
१३.४६ करोड
No. of employees
४३
News stories
From sources across the web
About ALX Oncology Holdings Inc
CEO-
Employees४३
Founded२०१५
HeadquartersSouth San Francisco, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitealxoncology.com
Analyst ratings
Based on 4 analysts giving stock ratings to ALXO in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ALXO in the last 3 months.
Highest
Current US$ १.९७
US$ ६.०० (+२०४.५७%)
Average
US$ ४.६७ (+१३७.०६%)
Lowest
US$ ४.०० (+१०३.०५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sam Slutsky
LifeSci Capital
Hold
Maintained
-
-
05/16/2026
Michael Yee
UBS
Buy
Maintained
US$ ६.००
+२०४.६%
05/12/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
US$ ४.००
+१०३%
05/11/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
US$ ४.००
+१०३%
05/11/2026
Derek Archila
Wells Fargo
Buy
Initiated
US$ ५.००
+१५३.८%
03/19/2026
Last report
२०२६ मे ८
Fiscal period
Q1 2026
EPS / Est. (USD)
-US$ ०.१७ / -US$ ०.१६
-७.९१%miss
Revenue / Est. (USD)
- / ०.००
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१.८० करोड
१.७४ करोड
१.७६ करोड
१.३६ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५४.५१ लाख
५०.९१ लाख
५३.७६ लाख
५३.६० लाख
Operating expense
२.३५ करोड
२.२५ करोड
२.३० करोड
१.९० करोड
Total operating expenses
२.३५ करोड
२.२५ करोड
२.३० करोड
१.९० करोड
Operating income
-२.३५ करोड
-२.२५ करोड
-२.३० करोड
-१.९० करोड
Other non operating income
-
-
-
१.८८ लाख
EBT including unusual items
-२.५९ करोड
-२.२१ करोड
-२.२८ करोड
-१.७९ करोड
EBT excluding unusual items
-२.२८ करोड
-२.२१ करोड
-२.२८ करोड
-१.७९ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.५९ करोड
-२.२१ करोड
-२.२८ करोड
-१.७९ करोड
Net profit margin
-
-
-
-
Earnings per share
-०.४४
-
-०.३७
-०.१५
Interest and investment income
११.०६ लाख
८.०२ लाख
५.७३ लाख
११.८२ लाख
Interest expense
-४.०५ लाख
-४.०८ लाख
-३.८३ लाख
-३.३१ लाख
Net interest expenses
७.०१ लाख
३.९४ लाख
१.९० लाख
८.५१ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२.३३ करोड
-२.२४ करोड
-२.२९ करोड
-१.८८ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer